Max Healthcare Institute Ltd

Max Healthcare Institute Ltd has provided an update on legal proceedings initiated by BRS Capital Two Pte. Limited against its subsidiary, Kalinga Hospital Ltd. The hearing at the National Company Law Tribunal (NCLT), Cuttack Bench, scheduled for September 28, 2026, was adjourned due to paucity of time. The matter has been rescheduled for further hearing on October 29, 2026. The company received a copy of the NCLT order on September 29, 2026. No other significant developments or settlements were reported.

Max Healthcare Institute Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. This closure will be effective from Thursday, October 1, 2026, and will remain in effect until 48 hours after the declaration of the company's unaudited financial results for the quarter and half-year ending September 30, 2026. The decision aligns with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The date for the board meeting to approve these financial results will be communicated separately. The disclosure will also be available on the company's website.

Max Healthcare Institute Ltd has received an ESG rating of '72', categorizing it as a 'Leader'. The rating was assigned by Niche Ninety Nine Capability and Certifications (OPC) Private Limited, a SEBI registered ESG Rating Provider. Notably, the company did not engage Niche99 for this rating; it was independently assigned based on the company's public disclosures. This disclosure will be hosted on the company's website.

Max Healthcare Institute Ltd. has disclosed further interlocutory petitions filed by BRS Capital Two Pte. Limited's legal representatives against its subsidiary, Kalinga Hospital Ltd. (KHL), and other parties. These petitions seek interim reliefs. The National Company Law Tribunal (NCLT), Cuttack Bench, heard the matter on September 8, 2026, and directed respondents, including Max Healthcare, to file a reply within one week. The next hearing is scheduled for September 28, 2026. The company received the NCLT order on September 10, 2026. This development follows earlier intimations regarding petitions filed by BRS Capital.

Max Healthcare Institute Ltd has successfully completed the infusion of approximately ₹87.87 Crore into its subsidiary, Kalinga Hospital Ltd (KHL), through a rights issue. The company has been allotted 50,21,212 equity shares. This infusion has increased Max Healthcare's shareholding in KHL from approximately 58.28% to 66.15%. Kalinga Hospital Ltd continues to remain a subsidiary of Max Healthcare Institute Ltd. This disclosure is also available on the company's website.

Max Healthcare Institute Ltd announced that its Renewable Energy and Subsidiary Investment Committee (RESIC) has approved an infusion of approximately ₹87.87 Crore into its subsidiary, Kalinga Hospital Ltd. This capital will be provided through a subscription to equity shares on a rights basis. The funds are intended to support Kalinga Hospital's capital expenditure, modernization program, strengthen its clinical and operational capabilities, optimize its capital structure, and meet general corporate requirements. The transaction is expected to be completed within the next 15 days. Kalinga Hospital Ltd reported a revenue of approximately ₹155.64 Crore for FY 2025-26 and has a paid-up capital of ₹21.54 Crore.

Max Healthcare Institute Ltd has inaugurated a new 400-bed tower at its Max Smart Super Speciality Hospital in Saket, New Delhi. The inauguration was attended by Union Home Minister Shri Amit Shah and Delhi Chief Minister Smt. Rekha Gupta. This expansion increases the hospital's total capacity to approximately 1,200 beds, making it the largest private hospital in Delhi by bed count. The new facility is equipped with advanced medical technologies, including robotic surgical systems, and aims to enhance tertiary and quaternary healthcare services in the region. Max Healthcare also highlighted its commitment to accessible healthcare, having provided free treatment worth ₹244 crore to 3.60 lakh patients last year.

Max Healthcare Institute Ltd's wholly-owned subsidiary, Alps Hospital Limited, has received a show cause cum demand notice from the Directorate General of Goods & Services Tax Intelligence (DGGI) for an alleged GST demand of ₹55,23,52,071 along with applicable interest and penalties. The notice pertains to the alleged non-payment of GST on variable management fees. The company's management is in the process of filing submissions against this demand. The alleged penalty amounts are also ₹55,23,52,071 under different sections of the Central Goods and Services Tax Act, 2017. This disclosure was made as per SEBI regulations.

Max Healthcare Institute Ltd has provided an update on legal proceedings involving its subsidiary, Kalinga Hospital Ltd (KHL). The National Company Law Tribunal (NCLT), Cuttack Bench, heard petitions filed by legal representatives of BRS Capital Two Pte. Limited. The hearing on August 19, 2026, was adjourned at the request of the petitioners. The matter has been rescheduled for further hearing on September 8, 2026. No other significant developments or financial impacts were reported in this update.

Max Healthcare Institute Ltd announced an upgrade in its Environmental, Social, and Governance (ESG) ratings by Crisil ESG Ratings & Analytics Limited. The company's ESG Rating has moved from CRISIL ESG 63 to CRISIL ESG 68, falling within the 'Strong' rating category. Concurrently, its Core ESG Rating was upgraded from CRISIL Core ESG 72 to CRISIL Core ESG 76. Crisil assigned these ratings independently based on the company's public disclosures, without any prior engagement with Max Healthcare. This disclosure highlights the company's improved ESG performance and commitment.